DnB Asset Management AS acquired a new stake in shares of electroCore, Inc. (NASDAQ:ECOR – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 11,112 shares of the company’s stock, valued at approximately $180,000. DnB Asset Management AS owned about 0.17% of electroCore at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Geode Capital Management LLC boosted its stake in electroCore by 10.3% in the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after purchasing an additional 5,951 shares in the last quarter. HighTower Advisors LLC bought a new position in shares of electroCore in the third quarter worth approximately $255,000. Finally, JPMorgan Chase & Co. lifted its stake in shares of electroCore by 31,250.0% in the fourth quarter. JPMorgan Chase & Co. now owns 3,762 shares of the company’s stock worth $61,000 after buying an additional 3,750 shares in the last quarter. 26.74% of the stock is owned by institutional investors.
electroCore Stock Up 6.9 %
ECOR opened at $6.62 on Thursday. The stock has a market capitalization of $47.62 million, a price-to-earnings ratio of -3.62 and a beta of 0.24. The firm has a 50 day moving average price of $13.51 and a 200-day moving average price of $12.42. electroCore, Inc. has a twelve month low of $5.32 and a twelve month high of $19.49.
Analyst Ratings Changes
Get Our Latest Stock Analysis on ECOR
Insider Buying and Selling at electroCore
In other news, Director Thomas J. Errico bought 6,000 shares of the company’s stock in a transaction on Monday, March 17th. The shares were acquired at an average cost of $8.10 per share, with a total value of $48,600.00. Following the completion of the transaction, the director now owns 256,401 shares of the company’s stock, valued at approximately $2,076,848.10. This trade represents a 2.40 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 19.70% of the company’s stock.
electroCore Company Profile
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Featured Articles
- Five stocks we like better than electroCore
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.